Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation
Among Chinese patients with type 2 diabetes, maintaining SBP ≤120 mmHg may not be an optimal target, in terms of the risk-benefit association of CVD and all-cause mortality.
Authors
- Ruile Fang
- S Chen
- Anxin Wang
- Shouling Wu
- Qin Xu
- Xue Tian
- Xue Xia
Institutions
- North China University of Science and Technology (CN)
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Kailuan General Hospital (CN)
- Beijing Institute of Neurosurgery (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1111/dom.70472
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00